Serum Institute of India has sought the drug regulator’s permission to conduct a small home trial.
New Delhi:
The Serum Institute of India, the world’s largest vaccine makers, has sought the drug regulator’s permission to conduct a small home trial of the Novavax Inc COVID-19 vaccine that was discovered to be 89.3% efficient in a UK trial, its CEO advised Reuters on Friday.
(Apart from the headline, this story has not been edited by NDTV workers and is revealed from a syndicated feed.)
